World news

Zebra Medical Vision, the AI medical imaging insights company, announced Wednesday it has received its fourth FDA 510(k) clearance for the HealthCXR device intended for the identification and triaging of pleural effusion in chest X-rays.

TORONTO – A team of Toronto doctors has completed the world’s first brain aneurysm surgery using robotics, leading to hope of better treatment for aneurysm and stroke patients, especially in areas where specialized surgical expertise isn’t available.

American contact lens retailer 1-800 Contacts announced this week that it entered into a definitive written agreement to acquire Israeli startup 6over6 Vision, which developed a smartphone-based healthcare platform that offers mobile vision tests.

Israeli startups Healthymize, a medical tech company that turns smart devices into patient monitoring devices for voice-affecting diseases, and Beyond Verbal, which developed voice-enabled AI to create vocal biomarkers for personalized health screening and emotion monitoring, have merged to form a company called Vocalis Health and announced the closure of a $9 million funding round this week. Venture capital fund aMoon, co-founded by Dr. Marius Nacht, led the round.

Israeli scientists say a new study has shown that a small molecule called PJ34 triggered the self-destruction of human pancreatic cancer cells in mice.

Israeli pharmaceutical company Raziel Therapeutics announced this week a $22 million Series C preferred stock financing led by Israeli VC firm Pontifax, with the participation of existing investors Dr. Shmuel Cabilly and Docor International. New investors included Catalyst Fund, Quark Venture and Peregrine Ventures.

Israeli biomedical tech company Theranica, which develops advanced wearable devices that address prevalent medical conditions and diseases, was named as one of 36 game-changing companies in 2020 by New York-based research firm CB Insights. It was the only Israeli company on the list.

Israeli AI medical imaging startup DiA Imaging Analysis will partner with IBM Watson Health, a provider of innovative, AI, enterprise imaging and interoperability solutions used by medical professionals worldwide, the company announced this week.

JRDF, a nonprofit global organization funding Type 1 diabetes research, has partnered with the Israel Science Foundation (ISF), the funding organization that provides governmental and public support for basic research in Israel, to launch a new initiative to invest in local research driving cures for Type 1 diabetes (T1D) in Israel.

VR system developed by former Israeli fighter pilots helps neurosurgeons rehearse difficult procedures and show the patient what will happen.

New technique from Israel uses cannabidiol to open a channel for drugs to target cancer cells only, potentially enabling a gentler course of chemo.

Corindus Vascular Robotics reported that it has completed its first machine-assisted brain surgery procedure in humans.

Scientists have made artificial nerve cells, paving the way for new ways to repair the human body. The tiny "brain chips" behave like the real thing and could one day be used to treat diseases such as Alzheimer's.

'Instead of having to check millions of molecules, we may check just 20, 100 or maybe up to 3,000 molecules,' says Jerusalem-based Pepticom.

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation (PAA), a leading supplier of intelligent laboratory automation solutions, today announced the optimization of the Cyto-Mine® Single Cell Analysis System through integration with PAA’s automated plate handler, S-LAB™. The addition of S-LAB to the Cyto-Mine provides researchers with a further streamlined solution for single cell analysis in biopharmaceutical workflows.

Food allergies are rising dramatically around the world. One startup thinks it may have the solution – a device that acts like a mini nose sniffing food for dangerous allergens.

“The mostly night-time atrial fibrillation was shown to be caused by a mutation in a gene (KCND2), encoding a crucial component of a potassium ion channel (Kv4.2) in the heart."

"We are encouraged by the emerging safety profile and initial signals of anti-tumor activity of COM701," said Compugen president and CEO Dr. Anat Cohen-Dayan.

Ahead of International Diabetes Day, November 14, Israeli startup Betalin Therapeutics announced that it is beginning the application process for clinical trials of its revolutionary artificial pancreas.

Your body is composed of about 10 trillion human cells. It’s also home to about 100 trillion tiny microbes, mainly bacteria that wield astonishing power over your health.